Kinpritma Sangha

Statistics

Publications

Citations

199

H-Index

Active since

2014

Affiliations

Feinstein Institute for Medical Research(Current)

University of California, Santa Cruz

Siemens Healthcare (United States)

Donald & Barbara Zucker School of Medicine at Hofstra/Northwell

Health Innovations (United States)

Kinpritma Sangha is an author at Feinstein Institute for Medical Research specializing in cost-effectiveness analysis, pharmacoeconomics, and cirrhosis.

ORCID

Publications per year

2014–2024

Publications

God is in the rain: The impact of rainfall-induced early social distancing on COVID-19 outbreaks

Ajay Shenoy, Bhavyaa Sharma, Guanghong Xu et al. · Journal of Health Economics · 2021 · 47 citations · Full text

Public Health, Infectious Disease Control, Preventive Medicine +17

God is in the Rain: The Impact of Rainfall-Induced Early Social Distancing on COVID-19 Outbreaks

Rolly Kapoor, Haedong Aiden Rho, Kinpritma Sangha et al. · SSRN Electronic Journal · 2020 · 39 citations · Full text

Public Health, Infectious Disease Control, Preventive Medicine +17

Cost-effectiveness of a precision hepatocellular carcinoma surveillance strategy in patients with cirrhosis

Szu‐Yu Zoe Kao, Kinpritma Sangha, Naoto Fujiwara et al. · EClinicalMedicine · 2024 · 33 citations · Full text

Medicine, Oncology, Pharmacoeconomics +17

Cost-effectiveness of MRE versus VCTE in staging fibrosis for nonalcoholic fatty liver disease (NAFLD) patients with advanced fibrosis

Kinpritma Sangha, Stephanie T. Chang, Ramsey Cheung et al. · Hepatology · 2023 · 32 citations

Medicine, Internal Medicine, Radiology +17

Cost-effectiveness of endovascular thrombectomy in acute stroke patients with large ischemic core

Maria X. Sanmartin, Jeffrey M. Katz, Jason Wang et al. · Journal of NeuroInterventional Surgery · 2022 · 23 citations

Public Affairs, Pharmacoeconomics, Surgery +16

1–5 of 7